BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 27339876)

  • 1. CRMPs Function in Neurons and Glial Cells: Potential Therapeutic Targets for Neurodegenerative Diseases and CNS Injury.
    Nagai J; Baba R; Ohshima T
    Mol Neurobiol; 2017 Aug; 54(6):4243-4256. PubMed ID: 27339876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation and cleavage of the family of collapsin response mediator proteins may play a central role in neurodegeneration after CNS trauma.
    Taghian K; Lee JY; Petratos S
    J Neurotrauma; 2012 Jun; 29(9):1728-35. PubMed ID: 22181040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Axonal Damage and Repair after Central Nervous System Injury.
    Egawa N; Lok J; Washida K; Arai K
    Transl Stroke Res; 2017 Feb; 8(1):14-21. PubMed ID: 27566737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the network.
    Xu X; Warrington AE; Bieber AJ; Rodriguez M
    CNS Drugs; 2011 Jul; 25(7):555-73. PubMed ID: 21699269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases.
    Quach TT; Honnorat J; Kolattukudy PE; Khanna R; Duchemin AM
    Mol Psychiatry; 2015 Sep; 20(9):1037-45. PubMed ID: 26077693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation in the central nervous system: Symphony of glial cells.
    Yang QQ; Zhou JW
    Glia; 2019 Jun; 67(6):1017-1035. PubMed ID: 30548343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cytoskeleton in axonal regeneration after neurodegenerative diseases and CNS injury.
    Li H; Zhu YH; Chi C; Wu HW; Guo J
    Rev Neurosci; 2014; 25(4):527-42. PubMed ID: 24622784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal regulation of immune responses in the central nervous system.
    Tian L; Rauvala H; Gahmberg CG
    Trends Immunol; 2009 Feb; 30(2):91-9. PubMed ID: 19144568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease.
    Good PF; Alapat D; Hsu A; Chu C; Perl D; Wen X; Burstein DE; Kohtz DS
    J Neurochem; 2004 Nov; 91(3):716-36. PubMed ID: 15485501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of neural regeneration.
    Jacobs WB; Fehlings MG
    Neurosurgery; 2003 Oct; 53(4):943-48; discussion 948-50. PubMed ID: 14519226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of collapsin response mediator proteins in the nervous system of embryonic zebrafish.
    Schweitzer J; Becker CG; Schachner M; Becker T
    Gene Expr Patterns; 2005 Aug; 5(6):809-16. PubMed ID: 15922676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collapsin Response Mediator Proteins: Their Biological Functions and Pathophysiology in Neuronal Development and Regeneration.
    Nakamura F; Ohshima T; Goshima Y
    Front Cell Neurosci; 2020; 14():188. PubMed ID: 32655376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
    Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
    Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concept and molecular basis of axonal regeneration after central nervous system injury.
    Muramatsu R; Yamashita T
    Neurosci Res; 2014 Jan; 78():45-9. PubMed ID: 23896200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders.
    Charrier E; Reibel S; Rogemond V; Aguera M; Thomasset N; Honnorat J
    Mol Neurobiol; 2003 Aug; 28(1):51-64. PubMed ID: 14514985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CRMP2 phosphorylation repairs CNS by regulating neurotrophic and inhibitory responses.
    Nagai J; Owada K; Kitamura Y; Goshima Y; Ohshima T
    Exp Neurol; 2016 Mar; 277():283-295. PubMed ID: 26795088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory and enzymatic functions of CRMPs in neuritogenesis, synaptic plasticity, and gene transcription.
    Hou ST
    Neurochem Int; 2020 Oct; 139():104795. PubMed ID: 32652266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain keratan sulfate and glial scar formation.
    Zhang H; Uchimura K; Kadomatsu K
    Ann N Y Acad Sci; 2006 Nov; 1086():81-90. PubMed ID: 17185507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Progress of Collapse Response Mediator Proteins in Neurodegenerative Diseases.
    Qin K; Xu S; Han Y; Wang S; Yan J; Shao X
    Dev Neurosci; 2022; 44(6):429-437. PubMed ID: 35249012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies and mechanisms of neuronal reprogramming.
    Wan Y; Ding Y
    Brain Res Bull; 2023 Jul; 199():110661. PubMed ID: 37149266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.